The New Rules for Pharma Access and Engagement

DTP, AI and the Future of Pharma Access 

In part two of our conversation with Mark Bard, he and Tyler Cowan turn the lens to patients, exploring how direct-to-patient models are disrupting traditional care and the implications of reduced physician involvement. They also tackle the rise of agentic AI, what it could enable and what commercial teams should be thinking about now. 

The New Rules of HCP Engagement 

Mark Bard, Co-Founder of Digital Health Coalition (DHC) joins host Tyler Cowan, VP, Commercial at Syneos Health, to unpack how the pandemic reshaped provider expectations and the continued impact on commercial teams. From feedback loops to content fatigue, to the myth of multichannel mastery, they break down what it takes to engage HCPs on their terms. 

Like what you’re hearing? Find the full Conversations on Commercialization podcast stream here. Also available anywhere you listen to podcasts.

Be sure to rate and review us!

We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].